 | • レポートコード：MRC23Q38920 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のウェアラブルインジェクターシステム市場について調査・分析し、世界のウェアラブルインジェクターシステム市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（オンボディ、オフボディ）、用途別セグメント分析（病院、クリニック、在宅医療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、BD、Sonceboz、Ypsomed、Elcam Medical、Enable Injections、Johnson & Johnson、United Therapeutics、West Pharmaceutical、CeQur Simplicity、Neuma、CCBio、Nemera、Amgen、Eitan Medical、Debiotech、MET、Weibel CDS、Repathaなどが含まれています。世界のウェアラブルインジェクターシステム市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ウェアラブルインジェクターシステム市場規模を推定する際に考慮しました。本レポートは、ウェアラブルインジェクターシステムの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ウェアラブルインジェクターシステムに関するビジネス上の意思決定に役立てることを目的としています。 ・ウェアラブルインジェクターシステム市場の概要 - 製品の定義 - ウェアラブルインジェクターシステムのタイプ別セグメント - 世界のウェアラブルインジェクターシステム市場規模：タイプ別分析（オンボディ、オフボディ） - ウェアラブルインジェクターシステムの用途別セグメント - 世界のウェアラブルインジェクターシステム市場規模：用途別分析（病院、クリニック、在宅医療） - 世界のウェアラブルインジェクターシステム市場規模予測（2018年-2029年） - ウェアラブルインジェクターシステムの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ウェアラブルインジェクターシステム市場の競争状況およびトレンド ・ウェアラブルインジェクターシステムの地域別市場規模 - 北米のウェアラブルインジェクターシステム市場規模（2018年-2029年） - アメリカのウェアラブルインジェクターシステム市場規模（2018年-2029年） - ヨーロッパのウェアラブルインジェクターシステム市場規模（2018年-2029年） - アジア太平洋のウェアラブルインジェクターシステム市場規模（2018年-2029年） - 中国のウェアラブルインジェクターシステム市場規模（2018年-2029年） - 日本のウェアラブルインジェクターシステム市場規模（2018年-2029年） - 韓国のウェアラブルインジェクターシステム市場規模（2018年-2029年） - インドのウェアラブルインジェクターシステム市場規模（2018年-2029年） - オーストラリアのウェアラブルインジェクターシステム市場規模（2018年-2029年） - 中南米のウェアラブルインジェクターシステム市場規模（2018年-2029年） - 中東・アフリカのウェアラブルインジェクターシステム市場規模（2018年-2029年） ・タイプ別セグメント：オンボディ、オフボディ - 世界のウェアラブルインジェクターシステムのタイプ別販売量（2018年-2023年） - 世界のウェアラブルインジェクターシステムのタイプ別売上（2018年-2023年） - 世界のウェアラブルインジェクターシステムのタイプ別価格 ・用途別セグメント：病院、クリニック、在宅医療 - 世界のウェアラブルインジェクターシステムの用途別販売量（2018年-2023年） - 世界のウェアラブルインジェクターシステムの用途別売上（2018年-2023年） - 世界のウェアラブルインジェクターシステムの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 BD、Sonceboz、Ypsomed、Elcam Medical、Enable Injections、Johnson & Johnson、United Therapeutics、West Pharmaceutical、CeQur Simplicity、Neuma、CCBio、Nemera、Amgen、Eitan Medical、Debiotech、MET、Weibel CDS、Repatha ・産業チェーンと販売チャネルの分析 - ウェアラブルインジェクターシステム産業チェーン分析 - ウェアラブルインジェクターシステムの主要原材料 - ウェアラブルインジェクターシステムの販売チャネル - ウェアラブルインジェクターシステムのディストリビューター - ウェアラブルインジェクターシステムの主要顧客 ・ウェアラブルインジェクターシステム市場ダイナミクス - ウェアラブルインジェクターシステムの業界動向 - ウェアラブルインジェクターシステム市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Wearable Injector System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Wearable Injector System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Wearable Injector System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Wearable Injector System include BD, Sonceboz, Ypsomed, Elcam Medical, Enable Injections, Johnson & Johnson, United Therapeutics, West Pharmaceutical and CeQur Simplicity, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Wearable Injector System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Injector System.
The Wearable Injector System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Wearable Injector System market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Injector System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
BD
Sonceboz
Ypsomed
Elcam Medical
Enable Injections
Johnson & Johnson
United Therapeutics
West Pharmaceutical
CeQur Simplicity
Neuma
CCBio
Nemera
Amgen
Eitan Medical
Debiotech
MET
Weibel CDS
Repatha
Segment by Type
On-body
Off-body
Segment by Application
Hospitals
Clinics
Home Care
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Injector System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Injector System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Wearable Injector System Market Overview
1.1 Product Overview and Scope of Wearable Injector System
1.2 Wearable Injector System Segment by Type
1.2.1 Global Wearable Injector System Market Value Comparison by Type (2023-2029)
1.2.2 On-body
1.2.3 Off-body
1.3 Wearable Injector System Segment by Application
1.3.1 Global Wearable Injector System Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Wearable Injector System Market Size Estimates and Forecasts
1.4.1 Global Wearable Injector System Revenue 2018-2029
1.4.2 Global Wearable Injector System Sales 2018-2029
1.4.3 Global Wearable Injector System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Wearable Injector System Market Competition by Manufacturers
2.1 Global Wearable Injector System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Wearable Injector System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Wearable Injector System Average Price by Manufacturers (2018-2023)
2.4 Global Wearable Injector System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Wearable Injector System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Injector System, Product Type & Application
2.7 Wearable Injector System Market Competitive Situation and Trends
2.7.1 Wearable Injector System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Wearable Injector System Players Market Share by Revenue
2.7.3 Global Wearable Injector System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Wearable Injector System Retrospective Market Scenario by Region
3.1 Global Wearable Injector System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Wearable Injector System Global Wearable Injector System Sales by Region: 2018-2029
3.2.1 Global Wearable Injector System Sales by Region: 2018-2023
3.2.2 Global Wearable Injector System Sales by Region: 2024-2029
3.3 Global Wearable Injector System Global Wearable Injector System Revenue by Region: 2018-2029
3.3.1 Global Wearable Injector System Revenue by Region: 2018-2023
3.3.2 Global Wearable Injector System Revenue by Region: 2024-2029
3.4 North America Wearable Injector System Market Facts & Figures by Country
3.4.1 North America Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Wearable Injector System Sales by Country (2018-2029)
3.4.3 North America Wearable Injector System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Wearable Injector System Market Facts & Figures by Country
3.5.1 Europe Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Wearable Injector System Sales by Country (2018-2029)
3.5.3 Europe Wearable Injector System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Injector System Market Facts & Figures by Country
3.6.1 Asia Pacific Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Wearable Injector System Sales by Country (2018-2029)
3.6.3 Asia Pacific Wearable Injector System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Wearable Injector System Market Facts & Figures by Country
3.7.1 Latin America Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Wearable Injector System Sales by Country (2018-2029)
3.7.3 Latin America Wearable Injector System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Injector System Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Injector System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Wearable Injector System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Wearable Injector System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Wearable Injector System Sales by Type (2018-2029)
4.1.1 Global Wearable Injector System Sales by Type (2018-2023)
4.1.2 Global Wearable Injector System Sales by Type (2024-2029)
4.1.3 Global Wearable Injector System Sales Market Share by Type (2018-2029)
4.2 Global Wearable Injector System Revenue by Type (2018-2029)
4.2.1 Global Wearable Injector System Revenue by Type (2018-2023)
4.2.2 Global Wearable Injector System Revenue by Type (2024-2029)
4.2.3 Global Wearable Injector System Revenue Market Share by Type (2018-2029)
4.3 Global Wearable Injector System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Wearable Injector System Sales by Application (2018-2029)
5.1.1 Global Wearable Injector System Sales by Application (2018-2023)
5.1.2 Global Wearable Injector System Sales by Application (2024-2029)
5.1.3 Global Wearable Injector System Sales Market Share by Application (2018-2029)
5.2 Global Wearable Injector System Revenue by Application (2018-2029)
5.2.1 Global Wearable Injector System Revenue by Application (2018-2023)
5.2.2 Global Wearable Injector System Revenue by Application (2024-2029)
5.2.3 Global Wearable Injector System Revenue Market Share by Application (2018-2029)
5.3 Global Wearable Injector System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BD Wearable Injector System Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Sonceboz
6.2.1 Sonceboz Corporation Information
6.2.2 Sonceboz Description and Business Overview
6.2.3 Sonceboz Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sonceboz Wearable Injector System Product Portfolio
6.2.5 Sonceboz Recent Developments/Updates
6.3 Ypsomed
6.3.1 Ypsomed Corporation Information
6.3.2 Ypsomed Description and Business Overview
6.3.3 Ypsomed Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ypsomed Wearable Injector System Product Portfolio
6.3.5 Ypsomed Recent Developments/Updates
6.4 Elcam Medical
6.4.1 Elcam Medical Corporation Information
6.4.2 Elcam Medical Description and Business Overview
6.4.3 Elcam Medical Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Elcam Medical Wearable Injector System Product Portfolio
6.4.5 Elcam Medical Recent Developments/Updates
6.5 Enable Injections
6.5.1 Enable Injections Corporation Information
6.5.2 Enable Injections Description and Business Overview
6.5.3 Enable Injections Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Enable Injections Wearable Injector System Product Portfolio
6.5.5 Enable Injections Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Johnson & Johnson Wearable Injector System Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 United Therapeutics
6.6.1 United Therapeutics Corporation Information
6.6.2 United Therapeutics Description and Business Overview
6.6.3 United Therapeutics Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 United Therapeutics Wearable Injector System Product Portfolio
6.7.5 United Therapeutics Recent Developments/Updates
6.8 West Pharmaceutical
6.8.1 West Pharmaceutical Corporation Information
6.8.2 West Pharmaceutical Description and Business Overview
6.8.3 West Pharmaceutical Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 West Pharmaceutical Wearable Injector System Product Portfolio
6.8.5 West Pharmaceutical Recent Developments/Updates
6.9 CeQur Simplicity
6.9.1 CeQur Simplicity Corporation Information
6.9.2 CeQur Simplicity Description and Business Overview
6.9.3 CeQur Simplicity Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 CeQur Simplicity Wearable Injector System Product Portfolio
6.9.5 CeQur Simplicity Recent Developments/Updates
6.10 Neuma
6.10.1 Neuma Corporation Information
6.10.2 Neuma Description and Business Overview
6.10.3 Neuma Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Neuma Wearable Injector System Product Portfolio
6.10.5 Neuma Recent Developments/Updates
6.11 CCBio
6.11.1 CCBio Corporation Information
6.11.2 CCBio Wearable Injector System Description and Business Overview
6.11.3 CCBio Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CCBio Wearable Injector System Product Portfolio
6.11.5 CCBio Recent Developments/Updates
6.12 Nemera
6.12.1 Nemera Corporation Information
6.12.2 Nemera Wearable Injector System Description and Business Overview
6.12.3 Nemera Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Nemera Wearable Injector System Product Portfolio
6.12.5 Nemera Recent Developments/Updates
6.13 Amgen
6.13.1 Amgen Corporation Information
6.13.2 Amgen Wearable Injector System Description and Business Overview
6.13.3 Amgen Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Amgen Wearable Injector System Product Portfolio
6.13.5 Amgen Recent Developments/Updates
6.14 Eitan Medical
6.14.1 Eitan Medical Corporation Information
6.14.2 Eitan Medical Wearable Injector System Description and Business Overview
6.14.3 Eitan Medical Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Eitan Medical Wearable Injector System Product Portfolio
6.14.5 Eitan Medical Recent Developments/Updates
6.15 Debiotech
6.15.1 Debiotech Corporation Information
6.15.2 Debiotech Wearable Injector System Description and Business Overview
6.15.3 Debiotech Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Debiotech Wearable Injector System Product Portfolio
6.15.5 Debiotech Recent Developments/Updates
6.16 MET
6.16.1 MET Corporation Information
6.16.2 MET Wearable Injector System Description and Business Overview
6.16.3 MET Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.16.4 MET Wearable Injector System Product Portfolio
6.16.5 MET Recent Developments/Updates
6.17 Weibel CDS
6.17.1 Weibel CDS Corporation Information
6.17.2 Weibel CDS Wearable Injector System Description and Business Overview
6.17.3 Weibel CDS Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Weibel CDS Wearable Injector System Product Portfolio
6.17.5 Weibel CDS Recent Developments/Updates
6.18 Repatha
6.18.1 Repatha Corporation Information
6.18.2 Repatha Wearable Injector System Description and Business Overview
6.18.3 Repatha Wearable Injector System Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Repatha Wearable Injector System Product Portfolio
6.18.5 Repatha Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Injector System Industry Chain Analysis
7.2 Wearable Injector System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Injector System Production Mode & Process
7.4 Wearable Injector System Sales and Marketing
7.4.1 Wearable Injector System Sales Channels
7.4.2 Wearable Injector System Distributors
7.5 Wearable Injector System Customers
8 Wearable Injector System Market Dynamics
8.1 Wearable Injector System Industry Trends
8.2 Wearable Injector System Market Drivers
8.3 Wearable Injector System Market Challenges
8.4 Wearable Injector System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer